Mark Anderson | Hackensack Meridian School of Medicine
A New Strategy for the Treatment of Patients with Type 1 Cardiorenal Syndrome with Impella® – Presented at A-CURE 2020.
Video Post
Related Content
 Pecha Kuchavideo Pecha Kucha: Can Mechanical Preload Reduction benefit PatientsModerators: Navin Kapur, MD (Tufts Medical Center, USA) and Dan Burkhoff, MD, PhD (Cardiovascular Research Foundation,... | 
Case Report: Congestive Hepatopathy treatment due to hemosiderosis in patient with chronic renal failure undergoing...Sisilia Alfina |